Clinical Research

Prognostic factors of patients undergoing percutaneous coronary intervention supported by extracorporeal membrane oxygenation

  • Qian ZHAO ,
  • Yan ZHANG ,
  • Qiao QIAO ,
  • Aiyun DENG
Expand
  • The First Clinical Medical College of Lanzhou University,Lanzhou 730000,China

Received date: 2023-08-04

  Online published: 2024-03-06

Abstract

Objective To explore the clinical value of transthoracic echocardiography (TTE) and related clinical indexesin the evaluation of percutaneous coronary intervention (PCI) supported by arteriovenous extracorporeal membrane oxygenation (VA-ECMO) in the treatment of patients with acute myocardial ischemia complicated by refractory cardiogenic shock. Methods The clinical data of 70 patients with acute myocardial ischemia complicated by refractory cardiogenic shock treated with VA-ECMO in the First Hospital of Lanzhou University from January 2022 to April 2023 were analyzed retrospectively. According to the success of VA-ECMO withdrawal, the patients were divided into success group (54 cases) and failure group (16 cases). The general data, Intraoperative condition, hemodynamic and biochemical indexes of the two groups were compared, and the independent risk factors affecting the clinical outcome were analyzed. Results The time of ECMO assistance in the success group was significantly shorter than that in the failure group (P < 0.05). There was no significant difference inother general information between the two groups(all P > 0.05). There was no significant difference in preoperative TIMI grade, number of diseased vascular branches, use of IVUS, ECG results and SYNTAX score between the two groups(all P > 0.05). Compared with those before treatment, arterial oxygen saturation (SaO2), left ventricular stroke volume (LVSV), left ventricular ejection fraction (LVEF), mitral annulus systolic velocity (Sa), aortic orifice forward flow spectrum (AV), velocity-time integral (VTI) and tricuspid annulus systolic displacement (TAPSE) increased significantly after ECMO plus PCI treatment (all P < 0.05). Left ventricular end systolic volume (LVESV) decreased significantly (P < 0.05). Compared with those in the failure group, the heart rate (HR), shock index (SI), blood lactic acid (Lac), C-reactive protein (CRP), aspartate aminotransferase (AST) and total bilirubin (TBIL) were lower in the success group (all P < 0.05). There was no significant difference in ECMO flow and SaO2 between the two groups(P > 0.05). Univariate logistic regression analysis showed that ECMO-supporting time, HR, Lac, CRP, AST and TBIL were the influencing factors of weaning failure in patients with acute myocardial ischemia complicated with refractory cardiogenic shock. Conclusion VA-ECMO combined with PCI can significantly improve cardiac function in patients with acute myocardial ischemia complicated by refractory cardiogenic shock.Echocardiographic parameters (LVESV, LVSV, LVEF, Sa, AV, VTI, TAPSE) and clinical indexes (HR, Lac, CRP, AST, TBIL) have certain clinical value for theprognosis.

Cite this article

Qian ZHAO , Yan ZHANG , Qiao QIAO , Aiyun DENG . Prognostic factors of patients undergoing percutaneous coronary intervention supported by extracorporeal membrane oxygenation[J]. The Journal of Practical Medicine, 2024 , 40(2) : 219 -224 . DOI: 10.3969/j.issn.1006-5725.2024.02.016

References

1 AISSAOUI N, PUYMIRAT E, DELMAS C, et al. Trends in cardiogenic shock complicating acute myocardial infarction [J]. Eur J Heart Fail, 2020, 22(4): 664-672. doi:10.1002/ejhf.1750
2 NAIDU S S, BARAN D A, JENTZER J C, et al. SCAI SHOCK Stage Classification Expert Consensus Update:A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM),and Society of Thoracic Surgeons (STS) in December 2021[J]. J Am Coll Cardiol, 2022, 79(9): 933-946.
3 TAVAZZI G, ROSSELLO X, GRAND J, et al. Epidemiology,monitoring,and treatment strategy in cardiogenic shock. A multinational cross-sectional survey of ESC-acute cardiovascular care association research section [J]. Eur Heart J Acute Cardiovasc Care, 2022, 11(9): 706-711. doi:10.1093/ehjacc/zuac087
4 PALACIOS ORDONEZ C, GARAN A R. The landscape of cardiogenic shock:epidemiology and current definitions [J]. Curr Opin Cardiol, 2022, 37(3): 236-240. doi:10.1097/hco.0000000000000957
5 IBANEZ B, JAMES S, AGEWALL S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2018, 39(2): 119-177.
6 UNGUREANU C, BLAIMONT M, TRINE H, et al. Prophylactic ECMO Support during Elective Coronary Percutaneous Interventions in High-Risk Patients:A Single-Center Experience [J]. J Interv Cardiol, 2023, 2023: 1-6. doi:10.1155/2023/5332038
7 中华医学会心血管病学分会心血管急重症学组, 中华心血管病杂志编辑委员会. 心原性休克诊断和治疗中国专家共识(2018)[J]. 中华心血管病杂志, 2019,47(4):265-277. doi:10.3760/cma.j.issn.0253-3758.2019.04.003
8 国家心血管病医疗质量控制中心专家委员会体外循环与体外生命支持专家工作组. 2021年中国体外生命支持医疗质量控制报告[J]. 中国循环杂志, 2022,37(12):1195-1201. doi:10.3969/j.issn.1000-3614.2022.12.004
9 马贵洲, 徐荣和, 蔡志雄,等. 复杂高危冠脉病变患者介入治疗现状及进展[J]. 实用医学杂志, 2021,37(24):3107-3112. doi:10.3969/j.issn.1006?5725.2021.24.003
10 RILEY R F, HENRY T D, MAHMUD E, et al. SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease [J]. Catheter Cardiovasc Interv, 2020, 96(2): 346-362. doi:10.1002/ccd.28994
11 BHATT D L, LOPES R D, HARRINGTON R A. Diagnosis and Treatment of Acute Coronary Syndromes: A Review [J]. JAMA, 2022, 327(7): 662-675. doi:10.1001/jama.2022.0358
12 曹毅, 李田昌, 陈宇,等. 体外膜氧合器辅助下经皮冠状动脉介入治疗高危复杂冠心病[J]. 中国介入影像与治疗学, 2022,19(5):273-277.
13 SAVVINOVA P P, MANCHUROV V N, HAES B L, et al. Mechanical circulatory support in refractory cardiogenic shock:retrospective register study [J]. Ter Arkh, 2022, 94(9): 1094-1098. doi:10.26442/00403660.2022.09.201886
14 CHOI K H, YANG J H, HONG D, et al. Optimal Timing of Venoarterial-Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Patients Suffering From Refractory Cardiogenic Shock [J]. Circ J, 2020, 84(9): 1502-1510. doi:10.1253/circj.cj-20-0259
15 OVERTCHOUK P, PASCAL J, LEBRETON G, et al. Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support [J]. EuroIntervention, 2018, 13(18): e2160-e2168. doi:10.4244/eij-d-17-01014
16 BAJRAKTARI G, BYTY?I I, HENEIN M Y, et al. Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials [J]. Int J Cardiol Heart Vasc, 2020, 29:100549. doi:10.1016/j.ijcha.2020.100549
17 MOHSIN M, FAROOQ M U, AKHTAR W, et al. Echocardiography in a critical care unit:a contemporary review [J]. Expert Rev Cardiovasc Ther, 2022, 20(1): 55-63. doi:10.1080/14779072.2022.2036124
18 杨慧燕, 黄生奇, 王静,等. 重症超声评估二尖瓣环收缩期运动峰值速度在体外膜肺氧合撤机前的应用[J]. 实用医学杂志, 2023,39(14):1830-1834. doi:10.3969/j.issn.1006-5725.2023.14.018
19 EZAD S M, RYAN M, DONKER D W, et al. Unloading the Left Ventricle in Venoarterial ECMO: In Whom, When, and How? [J]. Circulation, 2023, 147(16): 1237-1250. doi:10.1161/circulationaha.122.062371
20 JELENC M, JELENC B, NOVAK R, et al. Left ventricular venting in veno-arterial extracorporeal membrane oxygenation:A computer simulation study [J]. Int J Artif Organs, 2022, 45(10): 841-848. doi:10.1177/03913988221115444
21 HOCKSTEIN M A, SINGAM N S, PAPOLOS A I, et al. The Role of Echocardiography in Extracorporeal Membrane Oxygenation [J]. Curr Cardiol Rep, 2023, 25(1): 9-16. doi:10.1007/s11886-022-01827-w
22 NIROOMAND A, OLM F, LINDSTEDT S. Extracorporeal Membrane Oxygenation: Set-up, Indications, and Complications [J]. Adv Exp Med Biol, 2023, 1413: 291-312. doi:10.1007/978-3-031-26625-6_15
23 LASSUS J. Kidney and liver dysfunction in cardiogenic shock [J]. Curr Opin Crit Care, 2020, 26(4): 417-423. doi:10.1097/mcc.0000000000000746
24 O′BRIEN C, BEAUBIEN-SOULIGNY W, AMSALLEM M, et al. Cardiogenic Shock: Reflections at the Crossroad Between Perfusion, Tissue Hypoxia, and Mitochondrial Function [J]. Can J Cardiol, 2020, 36(2): 184-196. doi:10.1016/j.cjca.2019.11.020
Outlines

/